193 related articles for article (PubMed ID: 18645709)
21. T allele for VEGF-460 gene polymorphism at 5'-untranslated region is associated with higher susceptibility of leiomyoma.
Hsieh YY; Chang CC; Tsai FJ; Lin CC; Tsai CH
Biochem Genet; 2008 Jun; 46(5-6):356-61. PubMed ID: 18256925
[TBL] [Abstract][Full Text] [Related]
22. Age-dependent association of MDM2 promoter polymorphisms and uterine leiomyoma in South-East Iran: A preliminary report.
Salimi S; Hajizadeh A; Khodamian M; Pejman A; Fazeli K; Yaghmaei M
J Obstet Gynaecol Res; 2015 May; 41(5):729-34. PubMed ID: 25511444
[TBL] [Abstract][Full Text] [Related]
23. The polymorphisms of the CYP17 and CYP19 genes in endometrial cancer patients.
Szyłło K; Smolarz B; Romanowicz-Makowska H; Kulig A
Pol J Pathol; 2006; 57(1):35-40. PubMed ID: 16739881
[TBL] [Abstract][Full Text] [Related]
24. The effects of p21 gene C98A polymorphism on development of uterine leiomyoma in southeast Iranian women.
Salimi S; Hajizadeh A; Yaghmaei M; Rezaie S; Shahrakypour M; Teimoori B; Parache M; Naghavi A; Mokhtari M
Tumour Biol; 2016 Sep; 37(9):12497-12502. PubMed ID: 27337955
[TBL] [Abstract][Full Text] [Related]
25. CYP17 gene polymorphism and prostate cancer susceptibility in a Tunisian population.
Souiden Y; Mahdouani M; Chaieb K; Elkamel R; Mahdouani K
Cancer Epidemiol; 2011 Oct; 35(5):480-4. PubMed ID: 21193363
[TBL] [Abstract][Full Text] [Related]
26. Uterine leiomyoma is associated with a polymorphism in the interleukin 1-beta gene.
Pietrowski D; Thewes R; Sator M; Denschlag D; Keck C; Tempfer C
Am J Reprod Immunol; 2009 Aug; 62(2):112-7. PubMed ID: 19614627
[TBL] [Abstract][Full Text] [Related]
27. CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.
Madigan MP; Gao YT; Deng J; Pfeiffer RM; Chang BL; Zheng S; Meyers DA; Stanczyk FZ; Xu J; Hsing AW
Int J Cancer; 2003 Nov; 107(2):271-5. PubMed ID: 12949806
[TBL] [Abstract][Full Text] [Related]
28. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population.
Takemura N; Yoshida S; Kennedy S; Deguchi M; Ohara N; Maruo T
J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphism of CYP17 and breast cancer risk in Korean women.
Shin MH; Lee KM; Yang JH; Nam SJ; Kim JW; Yoo KY; Park SK; Noh DY; Ahn SH; Kim B; Kang D
Exp Mol Med; 2005 Feb; 37(1):11-7. PubMed ID: 15761247
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor beta gene polymorphisms and susceptibility to uterine fibroids.
Fischer C; Juhasz-Boess I; Lattrich C; Ortmann O; Treeck O
Gynecol Endocrinol; 2010 Jan; 26(1):4-9. PubMed ID: 19639498
[TBL] [Abstract][Full Text] [Related]
32. CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study.
Antognelli C; Del Buono C; Ludovini V; Gori S; Talesa VN; Crinò L; Barberini F; Rulli A
BMC Cancer; 2009 Apr; 9():115. PubMed ID: 19379515
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor alpha dinucleotide repeat and cytochrome P450c17alpha gene polymorphisms are associated with susceptibility to endometriosis.
Hsieh YY; Chang CC; Tsai FJ; Lin CC; Tsai CH
Fertil Steril; 2005 Mar; 83(3):567-72. PubMed ID: 15749482
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 -174G/C polymorphism in breast cancer and uterine leiomyoma patients: a population-based case control study.
Litovkin KV; Domenyuk VP; Bubnov VV; Zaporozhan VN
Exp Oncol; 2007 Dec; 29(4):295-8. PubMed ID: 18199986
[TBL] [Abstract][Full Text] [Related]
35. Association of estrogen and progesterone receptor gene polymorphisms and their respective hormones in uterine leiomyomas.
Veronica M; Ali A; Venkateshwari A; Mamata D; Nallari P
Tumour Biol; 2016 Jun; 37(6):8067-74. PubMed ID: 26715264
[TBL] [Abstract][Full Text] [Related]
36. CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women.
Ye Y; Cheng X; Luo HB; Liu L; Li YB; Hou YP
J Assist Reprod Genet; 2008 Aug; 25(8):389-94. PubMed ID: 18763031
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms of p53 promoter and susceptibility to uterine leiomyoma.
Ziaei E; Chaleshtori MH; Ziaei A; Dehkordi GB; Pooryamofrad A; Kashani S; Batenipoor M; Miraj S
Clin Exp Obstet Gynecol; 2016; 43(5):713-717. PubMed ID: 30074324
[TBL] [Abstract][Full Text] [Related]
38. Single nucleotide polymorphisms in the progesterone receptor gene and association with uterine leiomyoma tumor characteristics and disease risk.
Renner SP; Strick R; Fasching PA; Oeser S; Oppelt P; Mueller A; Beckmann MW; Strissel PL
Am J Obstet Gynecol; 2008 Dec; 199(6):648.e1-9. PubMed ID: 18691687
[TBL] [Abstract][Full Text] [Related]
39. Genotype distribution of estrogen receptor-alpha, catechol-O-methyltransferase, and cytochrome P450 17 gene polymorphisms in Caucasian women with uterine leiomyomas.
Denschlag D; Bentz EK; Hefler L; Pietrowski D; Zeillinger R; Tempfer C; Tong D
Fertil Steril; 2006 Feb; 85(2):462-7. PubMed ID: 16595228
[TBL] [Abstract][Full Text] [Related]
40. A polymorphism in the CYP17 gene is associated with prostate cancer risk.
Gsur A; Bernhofer G; Hinteregger S; Haidinger G; Schatzl G; Madersbacher S; Marberger M; Vutuc C; Micksche M
Int J Cancer; 2000 Aug; 87(3):434-7. PubMed ID: 10897051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
